rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Stryker Corporation

SYK · NYSE

Health CareMedical DevicesNot moving yetRobotics

SYK stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 6.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$986.9M
Officials’ trades on record
121

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$350.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

121 disclosed lines: House 78, Senate 14, executive 29; 29 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k21 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k17 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k10 Aug 2026filed 8 Oct 2026
Thomas H. Kean, Jr. House: U.S. House ClerkNJ07sold$1k–$15k22 Jul 2026filed 18 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k17 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$250k–$500k18 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k12 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k3 Jun 2026filed 22 Aug 2026
Thomas H. Kean, Jr. House: U.S. House ClerkNJ07sold$1k–$15k2 Jun 2026filed 15 Jul 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 8
WhoDidSharesTraded
Dylan Bram CrottyGroup Presidentsold441at $328.6121 Aug 2026filed 26 Aug 2026
Ronda E. StrykerDirectorsold40at $331.8119 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold440at $333.1819 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold200at $333.9319 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold80at $335.0619 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold320at $336.7919 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold2,308at $337.9819 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold11,257at $338.9019 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold10,812at $339.7119 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold16,612at $340.7119 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold3,274at $341.8419 Aug 2026filed 20 Aug 2026
Ronda E. StrykerDirectorsold3,852at $342.8019 Aug 2026filed 20 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Preston Wendell Wells Company insiderVP, Chief Financial Officer · last 24 Sep 20260 · 1
Donald J. Trump Executive branchWhite House Office · last 21 Aug 202615 · 9
Dylan Bram Crotty Company insiderGroup President · last 21 Aug 20260 · 1
Ronda E. Stryker Company insiderDirector · last 19 Aug 20260 · 1215
Debra King Company insiderOfficer · last 18 Aug 20260 · 1
Kimberly Ann Montagnino Company insiderVP, Chief Comm. Officer · last 1 Aug 20260 · 0
M. Kathryn Fink Company insiderVP, Chief HR Officer · last 1 Aug 20260 · 12
Robert S. Fletcher Company insiderVP, Chief Legal Officer · last 1 Aug 20260 · 5
Thomas H. Kean, Jr. HouseNJ07 · last 22 Jul 20260 · 12
Spencer S. Stiles Company insiderPresident and COO · last 1 Jun 20260 · 1
Andrew K. Silvernail Company insiderDirector · last 6 May 20260 · 0
Emmanuel Perez Maceda Company insiderDirector · last 6 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202518.4%
Operating profit marginFY 2025 · to 31 Dec 202519.5%
Free cash flow marginFY 2025 · to 31 Dec 202517.1%
Return on capital employedFY 2025 · to 31 Dec 202512.2%
Cash conversionFY 2025 · to 31 Dec 2025594%
Debt to equityFY 2025 · to 31 Dec 20250.71×
Interest coverFY 2025 · to 31 Dec 20258.40×
Research spendFY 2025 · to 31 Dec 20256.5%
Revenue growthFY 2025 · to 31 Dec 2025315%
Earnings per share growthFY 2025 · to 31 Dec 2025278%
Dividend growthFY 2025 · to 31 Dec 20254.8%
Share count trendFY 2025 · to 31 Jan 2026-1.0%

Analyst forecasts

No analyst forecasts yet.